Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tilly

Showing results (71-80 of 151) with videos related to

Pageof 16
Sort By:
Nouvelle Revue Francaise D'Hematologie|January 1, 1985
[Treatment of malignant hemopathies with aracytine in low doses. Analysis of 159 cases]S Castaigne, H Tilly, F Sigaux, et al.
The British Journal of Dermatology|April 1, 1995
Primary cutaneous medium and large cell lymphomas other than mycosis fungoides. An immunohistological and follow-up study on 54 cases. French Study Group for Cutaneous LymphomasP Joly, E Vasseur, E Esteve, et al.
Blood|April 15, 1994
Interleukin-2 treatment in lymphoma: a phase II multicenter studyC Gisselbrecht, D Maraninchi, J L Pico, et al.
Blood|May 1, 1994
LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patientsC Bastard, C Deweindt, J P Kerckaert, et al.
Blood|December 15, 1993
Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemiaS Castaigne, P Lefebvre, C Chomienne, et al.
Leukemia|April 14, 2000
Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytesF Lefrère, O Hermine, C Belanger, et al.
Leukemia|June 1, 1994
Residual disease in B-cell chronic lymphocytic leukemia patients and prognostic valueB Lenormand, M Bizet, C Fruchart, et al.
Leukemia & Lymphoma|January 1, 1993
A multicentric randomised study of alpha 2b interferon (IFN) and hydroxyurea (HU) with or without cytosine-arabinoside (Ara-c) in previously untreated patients with Ph+ chronic myelocytic leukemia (CML): preliminary cytogenetic resultsF Guilhot, J F Abgrall, J L Harousseau, et al.
Cancer|May 20, 1998
A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'AdulteN Mounier, P Morel, C Haioun, et al.
Blood|November 14, 1997
Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcomeH Tilly, P Gaulard, E Lepage, et al.
Pageof 16

Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
Nouvelle Revue Francaise D'Hematologie|January 1, 1985
[Treatment of malignant hemopathies with aracytine in low doses. Analysis of 159 cases]S Castaigne, H Tilly, F Sigaux, et al.
The British Journal of Dermatology|April 1, 1995
Primary cutaneous medium and large cell lymphomas other than mycosis fungoides. An immunohistological and follow-up study on 54 cases. French Study Group for Cutaneous LymphomasP Joly, E Vasseur, E Esteve, et al.
Blood|April 15, 1994
Interleukin-2 treatment in lymphoma: a phase II multicenter studyC Gisselbrecht, D Maraninchi, J L Pico, et al.
Blood|May 1, 1994
LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patientsC Bastard, C Deweindt, J P Kerckaert, et al.
Blood|December 15, 1993
Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemiaS Castaigne, P Lefebvre, C Chomienne, et al.
Leukemia|April 14, 2000
Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytesF Lefrère, O Hermine, C Belanger, et al.
Leukemia|June 1, 1994
Residual disease in B-cell chronic lymphocytic leukemia patients and prognostic valueB Lenormand, M Bizet, C Fruchart, et al.
Leukemia & Lymphoma|January 1, 1993
A multicentric randomised study of alpha 2b interferon (IFN) and hydroxyurea (HU) with or without cytosine-arabinoside (Ara-c) in previously untreated patients with Ph+ chronic myelocytic leukemia (CML): preliminary cytogenetic resultsF Guilhot, J F Abgrall, J L Harousseau, et al.
Cancer|May 20, 1998
A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'AdulteN Mounier, P Morel, C Haioun, et al.
Blood|November 14, 1997
Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcomeH Tilly, P Gaulard, E Lepage, et al.
Pageof 16